AstraZeneca racks up $275 million with vaccine sales

AstraZeneca racks up $275 million with vaccine sales

By Anna Domanska - May 03, 2021

AstraZeneca’s first-quarter earnings doubled, with its Covid-19 vaccine generating $275 million in revenue. The pharma company’s revenue for the quarter rose 15 percent

Read More
Denmark Austria temporarily suspend AstraZeneca vaccine over blood clot reports

Denmark Austria temporarily suspend AstraZeneca vaccine over blood clot reports

By Anna Domanska - Mar 15, 2021

Denmark has decided to temporarily suspend the use of the coronavirus vaccine developed by AstraZeneca and the University of Oxford due to reports of adverse blood clot reactions a

Read More
Oxford/AstraZeneca Covid vaccine to be approved by the UK within days

Oxford/AstraZeneca Covid vaccine to be approved by the UK within days

By Christy Gren - Dec 28, 2020

CEO of AstraZeneca, Pascal Soriot, recently stated that researchers are vehemently working to fish out the ‘winning formula’ to boost the Oxford COVID-19 vaccine. The C

Read More
AstraZenaca to Buy Rare Disease Specialist Alexion for $39 billion

AstraZenaca to Buy Rare Disease Specialist Alexion for $39 billion

By Christy Gren - Dec 15, 2020

Get upcoming M&A news and updates here at the nation’s fastest-growing CEO magazine, Industry Leaders.

Read More
AstraZeneca to Begin Supplying COVID-19 Vaccine in September

AstraZeneca to Begin Supplying COVID-19 Vaccine in September

By Anna Domanska - May 22, 2020

The University of Oxford and AstraZeneca Plc have begun recruiting over 10,000 subjects for advanced human trials of experimental COVID-19 vaccine. If everything goes as planned, t

Read More
Brexit shows no signs of mercy to drugmakers

Brexit shows no signs of mercy to drugmakers

By Anna Domanska - Sep 04, 2018

Britain’s departure from the EU has forced companies including AstraZeneca Plc, GlaxoSmithKline Plc and Merck & Co. to build stockpiles of their medicines in preparation for

Read More
Pfizer CEO Ian Read eager to court his company with ‘Botox Maker’ Allergan!

Pfizer CEO Ian Read eager to court his company with ‘Botox Maker’ Allergan!

By Carrie Ann - Oct 29, 2015

Pharmaceutical behemoth Pfizer has reportedly been in talks for acquisition of Allergan, which could be touted as the biggest acquisition of the year. This acquisition will create

Read More
Drug Giant AstraZeneca to Slash 1,600 jobs

Drug Giant AstraZeneca to Slash 1,600 jobs

By Anna Domanska - Mar 19, 2013

AstraZeneca PLC, the global pharmaceutical giant and the UK’s second biggest drug company, informed that it planned to restructure itself by introducing downsizing program and re

Read More